• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

各种血管舒张系统在卡托普利对人体的急性降压作用中的作用。

Role of various vasodepressor systems in the acute hypotensive effect of captopril in man.

作者信息

Lijnen P, Fagard R, Staessen J, Verschueren L J, Amery A

出版信息

Eur J Clin Pharmacol. 1981;20(1):1-8. doi: 10.1007/BF00554659.

DOI:10.1007/BF00554659
PMID:7030748
Abstract

The acute hypotensive effect of captopril 25 mg was investigated in 26 hypertensive patients (11 with essential and 15 with renal arterial disease). Intra-arterial blood pressure was recorded continuously and arterial blood was sampled for renin, angiotensin I and II, aldosterone, kininase II, catecholamines and prostaglandins. Captopril led to an increase in plasma renin activity, active and total plasma renin concentration and angiotensin I, a decrease in plasma kininase II activity, angiotensin II, aldosterone, prostaglandins E2 and F2 alpha and no change in plasma (nor) adrenaline, dopamine and inactive renin concentration. The hypotensive effect of captopril was related to the changes in plasma angiotensin II level and inversely to the changes in prostaglandin E2; the correlation coefficients were low, respectively 0.61 and -0.44. It is likely that the acute hypotensive effect of captopril to some extent is related to changes in plasma angiotensin II and in prostaglandins E2 and F2 alpha. There is no evidence for a role of the adrenergic systems in the hypotensive response.

摘要

对26例高血压患者(11例原发性高血压患者和15例肾动脉疾病患者)研究了25毫克卡托普利的急性降压作用。连续记录动脉内血压,并采集动脉血样本检测肾素、血管紧张素I和II、醛固酮、激肽酶II、儿茶酚胺和前列腺素。卡托普利导致血浆肾素活性、活性和总血浆肾素浓度以及血管紧张素I增加,血浆激肽酶II活性、血管紧张素II、醛固酮、前列腺素E2和F2α降低,血浆(去甲)肾上腺素、多巴胺和无活性肾素浓度无变化。卡托普利的降压作用与血浆血管紧张素II水平的变化有关,与前列腺素E2的变化呈负相关;相关系数较低,分别为0.61和-0.44。卡托普利的急性降压作用可能在一定程度上与血浆血管紧张素II以及前列腺素E2和F2α的变化有关。没有证据表明肾上腺素能系统在降压反应中起作用。

相似文献

1
Role of various vasodepressor systems in the acute hypotensive effect of captopril in man.各种血管舒张系统在卡托普利对人体的急性降压作用中的作用。
Eur J Clin Pharmacol. 1981;20(1):1-8. doi: 10.1007/BF00554659.
2
Acute changes in the renin-angiotensin-aldosterone system, catecholamines and prostaglandins during captopril in man.
Methods Find Exp Clin Pharmacol. 1980 Dec;2(6):293-301.
3
Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition.前列腺素合成抑制对卡托普利在人体中的急性降压作用的影响。
Br J Clin Pharmacol. 1982;14 Suppl 2(Suppl 2):87S-93S. doi: 10.1111/j.1365-2125.1982.tb02063.x.
4
Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man.卡托普利引起的前列腺素生成变化:与正常男性血管反应的关系。
J Clin Invest. 1980 Jun;65(6):1257-64. doi: 10.1172/JCI109788.
5
The effect of captopril on catecholamines, renin activity, angiotensin II and aldosterone in plasma during physical exercise in hypertensive patients.卡托普利对高血压患者运动期间血浆中儿茶酚胺、肾素活性、血管紧张素II及醛固酮的影响。
Eur J Clin Invest. 1981 Oct;11(5):389-95. doi: 10.1111/j.1365-2362.1981.tb02001.x.
6
Evidence that the acute hypotensive effect of captopril in dogs is not wholly explained by a reduction of plasma angiotensin II and its direct vasoconstrictor effect.卡托普利对犬的急性降压作用不能完全用血浆血管紧张素II的减少及其直接血管收缩作用来解释。
Clin Sci (Lond). 1980 Dec;59(6):451-6. doi: 10.1042/cs0590451.
7
[An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].血管紧张素转换酶抑制剂(卡托普利)长期给药对血压及肾素 - 血管紧张素 - 醛固酮系统影响的实验研究(作者译)
Nihon Naibunpi Gakkai Zasshi. 1980 Jun 20;56(6):868-83. doi: 10.1507/endocrine1927.56.6_868.
8
Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.卡托普利治疗:肾素、血管紧张素I和II、醛固酮及血压的剂间变化
Br J Clin Pharmacol. 1982 Jun;13(6):855-8. doi: 10.1111/j.1365-2125.1982.tb01878.x.
9
Hormonal responses to long-term converting enzyme inhibition in hypertensive patients.
Clin Pharmacol Ther. 1981 Sep;30(3):328-35. doi: 10.1038/clpt.1981.168.
10
Effect of captopril on urinary excretion of prostaglandins and renin-angiotensin-aldosterone system in normal subjects.卡托普利对正常受试者前列腺素尿排泄及肾素-血管紧张素-醛固酮系统的影响。
Acta Physiol Pharmacol Bulg. 1989;15(4):25-30.

本文引用的文献

1
Improved assay methods for renin "concentration" and "activity" in human plasma. Methods using selective denaturation of renin substrate.人血浆中肾素“浓度”和“活性”的改进测定方法。采用肾素底物选择性变性的方法。
Circ Res. 1967 Apr;20(4):391-402. doi: 10.1161/01.res.20.4.391.
2
Cardiovascular actions of prostaglandin Fa-alpha infusion in man.前列腺素Fa-α静脉输注对人体心血管系统的作用。
Eur J Pharmacol. 1969 Jan;5(2):117-20. doi: 10.1016/0014-2999(69)90019-3.
3
Radioimmunoassay of the A prostaglandins.前列腺素A的放射免疫测定
Prostaglandins. 1972 Jul;2(1):41-53. doi: 10.1016/0090-6980(72)90028-7.
4
Release of adrenal catecholamines by angiotensin I.血管紧张素I对肾上腺儿茶酚胺的释放作用。
J Pharmacol Exp Ther. 1971 Feb;176(2):366-76.
5
Comparison between a biological and a radioimmunological assay of plasma renin concentration.血浆肾素浓度的生物学检测法与放射免疫检测法的比较。
FEBS Lett. 1976 Jan 1;61(1):32-3. doi: 10.1016/0014-5793(76)80164-0.
6
Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine.血浆去甲肾上腺素、肾上腺素和多巴胺的同步单同位素放射酶法测定
Life Sci. 1977 Sep 1;21(5):625-36. doi: 10.1016/0024-3205(77)90070-4.
7
Mechanism of hypotensive effect during betaadrenergic blockade in hypertensive patients.高血压患者β肾上腺素能阻滞剂治疗期间的降压机制。
Am Heart J. 1976 May;91(5):634-42. doi: 10.1016/s0002-8703(76)80149-4.
8
Direct radioimmunoassay of plasma aldosterone in normal subjects.
Clin Chim Acta. 1978 Mar 15;84(3):305-14. doi: 10.1016/0009-8981(78)90246-2.
9
Faster radioimmunoassay of angiotensin I at 37 degrees C.37摄氏度下血管紧张素I的快速放射免疫测定法。
Clin Chem. 1978 Jan;24(1):115-8.
10
Converting enzyme inhibition with an orally active compound in hypertensive man.在高血压患者中使用口服活性化合物进行转换酶抑制。
Hypertension. 1979 Jan-Feb;1(1):39-46. doi: 10.1161/01.hyp.1.1.39.